Immediate Impact
6 from Science/Nature 68 standout
Citing Papers
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Revisiting the Stress Concept: Implications for Affective Disorders
2020 Standout
Works of B. Maccagno being referenced
Mineralocorticoid Receptor Blockade by Canrenoate Increases Both Spontaneous and Stimulated Adrenal Function in Humans1
2001
Glucagon Is an ACTH Secretagogue as Effective as hCRH after Intramuscolar Administration while It Is Ineffective When Given Intravenously in Normal Subjects
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| B. Maccagno | 376 | 116 | 154 | 207 | 23 | 515 | |
| Daniel Désir | 198 | 187 | 120 | 266 | 24 | 623 | |
| Keith M. Fairhall | 282 | 138 | 75 | 229 | 23 | 496 | |
| Jaya Pamidimukkala | 256 | 86 | 69 | 90 | 14 | 551 | |
| Viviane Guillaume | 204 | 132 | 237 | 153 | 19 | 582 | |
| Werner Kern | 136 | 107 | 62 | 164 | 17 | 503 | |
| Luis Lima | 412 | 135 | 59 | 127 | 26 | 620 | |
| J. W. Kendall | 234 | 102 | 217 | 111 | 15 | 561 | |
| Müller Ee | 151 | 236 | 56 | 260 | 28 | 521 | |
| A Velardo | 170 | 88 | 98 | 145 | 37 | 473 | |
| A. Châtelain | 210 | 88 | 219 | 61 | 32 | 541 |
All Works
Loading papers...